These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30261315)

  • 1. Proportions of resting memory T cells and monocytes in blood have prognostic significance in idiopathic pulmonary fibrosis.
    Liu YZ; Saito S; Morris GF; Miller CA; Li J; Lefante JJ
    Genomics; 2019 Dec; 111(6):1343-1350. PubMed ID: 30261315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of a Hypoxia-Immune-Related Microenvironment Gene Signature and Prediction Model for Idiopathic Pulmonary Fibrosis.
    Li X; Cai H; Cai Y; Zhang Q; Ding Y; Zhuang Q
    Front Immunol; 2021; 12():629854. PubMed ID: 34194423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant populations of circulating T follicular helper cells and regulatory B cells underlying idiopathic pulmonary fibrosis.
    Asai Y; Chiba H; Nishikiori H; Kamekura R; Yabe H; Kondo S; Miyajima S; Shigehara K; Ichimiya S; Takahashi H
    Respir Res; 2019 Nov; 20(1):244. PubMed ID: 31694639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD247, a Potential T Cell-Derived Disease Severity and Prognostic Biomarker in Patients With Idiopathic Pulmonary Fibrosis.
    Li Y; Chen S; Li X; Wang X; Li H; Ning S; Chen H
    Front Immunol; 2021; 12():762594. PubMed ID: 34880861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-Modal Characterization of Monocytes in Idiopathic Pulmonary Fibrosis Reveals a Primed Type I Interferon Immune Phenotype.
    Fraser E; Denney L; Antanaviciute A; Blirando K; Vuppusetty C; Zheng Y; Repapi E; Iotchkova V; Taylor S; Ashley N; St Noble V; Benamore R; Hoyles R; Clelland C; Rastrick JMD; Hardman CS; Alham NK; Rigby RE; Simmons A; Rehwinkel J; Ho LP
    Front Immunol; 2021; 12():623430. PubMed ID: 33746960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-Cell Profiling Reveals Immune Aberrations in Progressive Idiopathic Pulmonary Fibrosis.
    Unterman A; Zhao AY; Neumark N; Schupp JC; Ahangari F; Cosme C; Sharma P; Flint J; Stein Y; Ryu C; Ishikawa G; Sumida TS; Gomez JL; Herazo-Maya JD; Dela Cruz CS; Herzog EL; Kaminski N
    Am J Respir Crit Care Med; 2024 Aug; 210(4):484-496. PubMed ID: 38717443
    [No Abstract]   [Full Text] [Related]  

  • 7. Construction of an artificial neural network diagnostic model and investigation of immune cell infiltration characteristics for idiopathic pulmonary fibrosis.
    Zhang H; Hua H; Wang C; Zhu C; Xia Q; Jiang W; Hu X; Zhang Y
    BMC Pulm Med; 2024 Sep; 24(1):458. PubMed ID: 39289672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S100A12 as Biomarker of Disease Severity and Prognosis in Patients With Idiopathic Pulmonary Fibrosis.
    Li Y; He Y; Chen S; Wang Q; Yang Y; Shen D; Ma J; Wen Z; Ning S; Chen H
    Front Immunol; 2022; 13():810338. PubMed ID: 35185901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of IFN-γ, sCD163, CCL2 and CXCL10 involved in acute exacerbation of idiopathic pulmonary fibrosis.
    Gui X; Qiu X; Tian Y; Xie M; Li H; Gao Y; Zhuang Y; Cao M; Ding H; Ding J; Zhang Y; Cai H
    Int Immunopharmacol; 2019 May; 70():208-215. PubMed ID: 30851700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased activated regulatory T cells proportion correlate with the severity of idiopathic pulmonary fibrosis.
    Hou Z; Ye Q; Qiu M; Hao Y; Han J; Zeng H
    Respir Res; 2017 Sep; 18(1):170. PubMed ID: 28886713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Impact of Emphysema Evaluated by High-Resolution Computed Tomography on Idiopathic Pulmonary Fibrosis Diagnosed by Surgical Lung Biopsy.
    Kohashi Y; Arai T; Sugimoto C; Tachibana K; Akira M; Kitaichi M; Hayashi S; Inoue Y
    Respiration; 2016; 92(4):220-228. PubMed ID: 27576553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A retrospective cohort study of prognostic factors for death in patients with idiopathic pulmonary fibrosis].
    Li ZH; Peng SC; Kang J; Hou XM; Yu RJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 Dec; 33(12):887-91. PubMed ID: 21211406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-life experiences in a single center: efficacy of pirfenidone in idiopathic pulmonary fibrosis and fibrotic idiopathic non-specific interstitial pneumonia patients.
    Feng H; Zhao Y; Li Z; Kang J
    Ther Adv Respir Dis; 2020; 14():1753466620963015. PubMed ID: 33070705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the prognostic value of MMP-7 in idiopathic pulmonary fibrosis.
    Tzouvelekis A; Herazo-Maya JD; Slade M; Chu JH; Deiuliis G; Ryu C; Li Q; Sakamoto K; Ibarra G; Pan H; Gulati M; Antin-Ozerkis D; Herzog EL; Kaminski N
    Respirology; 2017 Apr; 22(3):486-493. PubMed ID: 27761978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary function and survival in idiopathic vs secondary usual interstitial pneumonia.
    Strand MJ; Sprunger D; Cosgrove GP; Fernandez-Perez ER; Frankel SK; Huie TJ; Olson AL; Solomon J; Brown KK; Swigris JJ
    Chest; 2014 Sep; 146(3):775-785. PubMed ID: 24700149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum extracellular vesicular miR-21-5p is a predictor of the prognosis in idiopathic pulmonary fibrosis.
    Makiguchi T; Yamada M; Yoshioka Y; Sugiura H; Koarai A; Chiba S; Fujino N; Tojo Y; Ota C; Kubo H; Kobayashi S; Yanai M; Shimura S; Ochiya T; Ichinose M
    Respir Res; 2016 Sep; 17(1):110. PubMed ID: 27596748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The predictors of mortality in IPF - Does emphysema change the prognosis?
    Tokgoz Akyıl F; Sevim T; Akman C; Aksoy E; Ağca M; Aktas O; Akyıl M
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):267-274. PubMed ID: 27758993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [
    Justet A; Laurent-Bellue A; Thabut G; Dieudonné A; Debray MP; Borie R; Aubier M; Lebtahi R; Crestani B
    Respir Res; 2017 Apr; 18(1):74. PubMed ID: 28449678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibody status is not associated with change in lung function or survival in patients with idiopathic pulmonary fibrosis.
    Goobie GC; Ford-Sahibzada CA; Fritzler MJ; Johannson KA; Fell CD
    Respir Med; 2019 Jul; 153():85-90. PubMed ID: 31176275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Independent Clinical Factors Relevant to Prognosis of Patients with Idiopathic Pulmonary Fibrosis.
    Song H; Sun D; Ban C; Liu Y; Zhu M; Ye Q; Yan W; Ren Y; Dai H
    Med Sci Monit; 2019 Jun; 25():4193-4201. PubMed ID: 31166938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.